- Home
- BSET vs EVMN Comparison
BSET vs EVMN Comparison
Compare BSET & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BSET | EVMN |
|---|---|---|
| Founded | 1902 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.2M | 185.1M |
| IPO Year | 1995 | 2025 |
Fundamental Metrics
Financial Performance| Metric | BSET | EVMN |
|---|---|---|
| Price | $22.80 | $6.69 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | ★ $23.00 | $22.33 |
| AVG Volume (30 Days) | 26.9K | ★ 1.1M |
| Earning Date | 09-30-2026 | 11-11-2026 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | ★ 163.06 | 75.23 |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $456,855,000.00 | $13,000,000.00 |
| Revenue This Year | $0.85 | N/A |
| Revenue Next Year | $3.42 | N/A |
| P/E Ratio | $37.25 | ★ N/A |
| Revenue Growth | 0.96 | ★ 85.71 |
| 52 Week Low | $13.17 | $4.94 |
| 52 Week High | $22.95 | $33.20 |
Technical Indicators
Market Signals| Indicator | BSET | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 64.73 | 49.09 |
| Support Level | $13.90 | $4.94 |
| Resistance Level | N/A | $13.35 |
| Average True Range (ATR) | 0.71 | 0.52 |
| MACD | 0.01 | 0.35 |
| Stochastic Oscillator | 73.74 | 77.31 |
Price Performance
Historical ComparisonAbout BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.